Dorsey Wright & Associates Biocryst Pharmaceuticals Inc Transaction History

Dorsey Wright & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 02, 2019	SELL	$2.91 - $9.15 $3,160 - $9,936	-1,086 Closed	0 $0
Q1 2019 Apr 04, 2019	SELL	$7.38 - $9.72 $7,992 - $10,526	-1,083 Reduced 49.93%	1,086 $9,000
Q4 2018 Jan 07, 2019	BUY	$6.51 - $9.6 $14,120 - $20,822	2,169 New	2,169 $18,000

278

171M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.